Shubin Hong
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
-
- Thyroid Cancer Diagnosis and Treatment 10
- Otorhinolaryngology top 10%
-
- Ophthalmology and Eye Disorders 5
-
- Ferroptosis and cancer prognosis 7
-
- Genetic Associations and Epidemiology 4
-
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
- Journals
- Journal of Clinical Oncology (4 papers)PLoS ONE (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Shubin Hong
41 papers receiving 644 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 211
- Endocrinology, Diabetes and Metabolism 210
- Otorhinolaryngology 25
- Nephrology 34
- Pathology and Forensic Medicine 82
Countries citing papers authored by Shubin Hong
This map shows the geographic impact of Shubin Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubin Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubin Hong more than expected).
Fields of papers citing papers by Shubin Hong
This network shows the impact of papers produced by Shubin Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubin Hong. The network helps show where Shubin Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shubin Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 24 | |
| 10 | 2022 | 20 | |
| 11 | 2022 | 42 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 17 | |
| 17 | 2017 | 52 | |
| 18 | 2017 | 28 | |
| 19 | 2016 | 9 | |
| 20 | 2015 | 9 |
About Shubin Hong
Shubin Hong is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 44 papers that have together received 650 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (7 papers), Ferroptosis and cancer prognosis (7 papers), Ophthalmology and Eye Disorders (5 papers), Cancer-related molecular mechanisms research (4 papers), Genetic Associations and Epidemiology (4 papers), Epigenetics and DNA Methylation (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (211 citations), Endocrinology, Diabetes and Metabolism (210 citations) and Otorhinolaryngology (25 citations). Shubin Hong has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Haipeng Xiao, Yanbing Li, Shuang Yu, Quan Zhang, Hongyu Guan, Yanrui Huang, Yujie Liu, Weiming Lv, Wei Xian and Shuwei Chen. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.